Pharmaceutical giant Pfizer announced on Tuesday that it would delay drug price increases after having an “extensive” conversation with President Donald Trump. The conversation took place between Pfizer CEO Ian Read and the president, with Read stating, “Pfizer shares the President’s concern for patients and commitment to providing affordable access to the medicines they need.” … Continue reading “Pfizer Will Postpone Drug Increases For This Reason”
Tag: ian read
Biotech & Pharma
Pfizer Sees a 50% Rise in Profit with the Help of These Drugs
Top U.S. drug maker Pfizer just reported its second quarter earnings report that beat the…
August 1, 2017
Biotech & Pharma
Pfizer (PFE) Just Ditched Its High-Profile Cholesterol Drug
Shares of Pfizer dropped about 2% after the pharma giant decided to scrap its high-profile…
November 1, 2016